Close Menu

In PLoS One this week, a research team led by investigators at the University of Maryland School of Medicine show that polymorphisms of CYP19A1, a gene that encodes aromatase, "are associated with survival among patients with cardiovascular disease in a sex-specific manner." In case-control studies, the Maryland-led team genotyped participants for six CYP19A1 SNPs. For one SNP in particular — -81371 C — the team observed a 78 percent increase in mortality for men with acute coronary syndrome, as compared with affected women. The authors say that theirs is the first "study ...

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.